Last reviewed · How we verify
Efficacy of Reslizumab for the Treatment of Chronic Rhinosinusitis A Double Blind, Randomized, Placebo-controlled, Phase III Trial
The purpose of this study is to determine whether Reslizumab is effective for the treatment of chronic sinusitis.
Details
| Lead sponsor | Joshua S. Jacobs |
|---|---|
| Phase | Phase 3 |
| Status | UNKNOWN |
| Enrolment | 30 |
| Start date | 2016-06 |
| Completion | 2019-07 |
Conditions
- Sinusitis
Interventions
- Reslizumab
- Placebo
Primary outcomes
- Change in computed tomography (CT) score — 24 weeks
Countries
United States